{"entity":{"type":"insider","cik":"0001586752","url":"/insider/0001586752","json_url":"/insider/0001586752.json","name":"Ertel Steven D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":53,"n_filings":22,"first":"2014-04-24","last":"2017-01-06","span_basis":"filed_date"},"name_variants":[{"name":"Ertel Steven D","source":"filing","n_filings":22,"first_seen":"2014-04-24","last_seen":"2017-01-06"}],"transactions":[{"id":4897983,"accession":"0001179110-17-000680","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-000680","line_url":"/filing/0001179110-17-000680#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":27.61,"price_display":"27.61","price_state":"stated","total_value":52459.0,"total_display":"52,459.00","shares_owned_after":129077.0,"shares_owned_after_display":"129,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-04","filed_date":"2017-01-06","scope":"insider"},{"id":4897978,"accession":"0001179110-17-000680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-000680","line_url":"/filing/0001179110-17-000680#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":26.92,"price_display":"26.92","price_state":"stated","total_value":16152.0,"total_display":"16,152.00","shares_owned_after":130977.0,"shares_owned_after_display":"130,977","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-04","filed_date":"2017-01-06","scope":"insider"},{"id":2768572,"accession":"0001179110-16-027492","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-16-027492","line_url":"/filing/0001179110-16-027492#line-6","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3466.0,"shares_display":"3,466","price_per_share":32.89,"price_display":"32.89","price_state":"stated","total_value":113996.74,"total_display":"113,996.74","shares_owned_after":127656.0,"shares_owned_after_display":"127,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-05","filed_date":"2016-07-06","scope":"insider"},{"id":2768570,"accession":"0001179110-16-027492","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-16-027492","line_url":"/filing/0001179110-16-027492#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":34.13,"price_display":"34.13","price_state":"stated","total_value":17065.0,"total_display":"17,065.00","shares_owned_after":127156.0,"shares_owned_after_display":"127,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-05","filed_date":"2016-07-06","scope":"insider"},{"id":2768566,"accession":"0001179110-16-027492","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-16-027492","line_url":"/filing/0001179110-16-027492#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28304.0,"shares_display":"28,304","price_per_share":34.77,"price_display":"34.77","price_state":"stated","total_value":984130.08,"total_display":"984,130.08","shares_owned_after":127156.0,"shares_owned_after_display":"127,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-01","filed_date":"2016-07-06","scope":"insider"},{"id":2231468,"accession":"0001179110-16-022919","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-16-022919","line_url":"/filing/0001179110-16-022919#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32270.0,"shares_display":"32,270","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":1032640.0,"total_display":"1,032,640.00","shares_owned_after":127156.0,"shares_owned_after_display":"127,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-07","filed_date":"2016-04-08","scope":"insider"},{"id":8172794,"accession":"0001104659-15-065570","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-065570","line_url":"/filing/0001104659-15-065570#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":33.61,"price_display":"33.61","price_state":"stated","total_value":67220.0,"total_display":"67,220.00","shares_owned_after":119656.0,"shares_owned_after_display":"119,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-15","filed_date":"2015-09-16","scope":"insider"},{"id":8479347,"accession":"0001179110-15-012359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-012359","line_url":"/filing/0001179110-15-012359#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":30.46,"price_display":"30.46","price_state":"stated","total_value":60920.0,"total_display":"60,920.00","shares_owned_after":57656.0,"shares_owned_after_display":"57,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-19","scope":"insider"},{"id":8916318,"accession":"0001179110-15-011302","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-011302","line_url":"/filing/0001179110-15-011302#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":31.38,"price_display":"31.38","price_state":"stated","total_value":62760.0,"total_display":"62,760.00","shares_owned_after":57656.0,"shares_owned_after_display":"57,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-15","filed_date":"2015-07-17","scope":"insider"},{"id":8073254,"accession":"0001179110-15-009913","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-009913","line_url":"/filing/0001179110-15-009913#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":31.11,"price_display":"31.11","price_state":"stated","total_value":62220.0,"total_display":"62,220.00","shares_owned_after":57656.0,"shares_owned_after_display":"57,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-16","scope":"insider"},{"id":8801086,"accession":"0001179110-15-008005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-008005","line_url":"/filing/0001179110-15-008005#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1285.0,"shares_display":"1,285","price_per_share":31.59,"price_display":"31.59","price_state":"stated","total_value":40593.15,"total_display":"40,593.15","shares_owned_after":57656.0,"shares_owned_after_display":"57,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-15","filed_date":"2015-05-18","scope":"insider"},{"id":8801085,"accession":"0001179110-15-008005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-008005","line_url":"/filing/0001179110-15-008005#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":715.0,"shares_display":"715","price_per_share":31.32,"price_display":"31.32","price_state":"stated","total_value":22393.8,"total_display":"22,393.80","shares_owned_after":58941.0,"shares_owned_after_display":"58,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-15","filed_date":"2015-05-18","scope":"insider"},{"id":8714843,"accession":"0001179110-15-006400","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-006400","line_url":"/filing/0001179110-15-006400#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":33.58,"price_display":"33.58","price_state":"stated","total_value":67160.0,"total_display":"67,160.00","shares_owned_after":52656.0,"shares_owned_after_display":"52,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-15","filed_date":"2015-04-17","scope":"insider"},{"id":8800980,"accession":"0001179110-15-004400","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-15-004400","line_url":"/filing/0001179110-15-004400#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2557.0,"shares_display":"2,557","price_per_share":40.54,"price_display":"40.54","price_state":"stated","total_value":103660.78,"total_display":"103,660.78","shares_owned_after":55099.0,"shares_owned_after_display":"55,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-04","filed_date":"2015-03-06","scope":"insider"},{"id":8800979,"accession":"0001179110-15-004400","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-15-004400","line_url":"/filing/0001179110-15-004400#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2043.0,"shares_display":"2,043","price_per_share":41.28,"price_display":"41.28","price_state":"stated","total_value":84335.04,"total_display":"84,335.04","shares_owned_after":53056.0,"shares_owned_after_display":"53,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-04","filed_date":"2015-03-06","scope":"insider"},{"id":8800978,"accession":"0001179110-15-004400","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-004400","line_url":"/filing/0001179110-15-004400#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (EVP & Chief Operating Officer)","officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":42.05,"price_display":"42.05","price_state":"stated","total_value":16820.0,"total_display":"16,820.00","shares_owned_after":52656.0,"shares_owned_after_display":"52,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-04","filed_date":"2015-03-06","scope":"insider"},{"id":8714631,"accession":"0001179110-15-001830","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-15-001830","line_url":"/filing/0001179110-15-001830#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":38.33,"price_display":"38.33","price_state":"stated","total_value":107324.0,"total_display":"107,324.00","shares_owned_after":54856.0,"shares_owned_after_display":"54,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-02","filed_date":"2015-02-04","scope":"insider"},{"id":8714629,"accession":"0001179110-15-001830","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-001830","line_url":"/filing/0001179110-15-001830#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":39.03,"price_display":"39.03","price_state":"stated","total_value":74157.0,"total_display":"74,157.00","shares_owned_after":52956.0,"shares_owned_after_display":"52,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-02","filed_date":"2015-02-04","scope":"insider"},{"id":8714626,"accession":"0001179110-15-001830","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-001830","line_url":"/filing/0001179110-15-001830#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":39.95,"price_display":"39.95","price_state":"stated","total_value":11985.0,"total_display":"11,985.00","shares_owned_after":52656.0,"shares_owned_after_display":"52,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-02","filed_date":"2015-02-04","scope":"insider"},{"id":8365733,"accession":"0001179110-15-000987","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-000987","line_url":"/filing/0001179110-15-000987#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":40.53,"price_display":"40.53","price_state":"stated","total_value":72954.0,"total_display":"72,954.00","shares_owned_after":52856.0,"shares_owned_after_display":"52,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-15","filed_date":"2015-01-16","scope":"insider"},{"id":8365726,"accession":"0001179110-15-000987","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-000987","line_url":"/filing/0001179110-15-000987#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":41.05,"price_display":"41.05","price_state":"stated","total_value":8210.0,"total_display":"8,210.00","shares_owned_after":52656.0,"shares_owned_after_display":"52,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-15","filed_date":"2015-01-16","scope":"insider"},{"id":8772303,"accession":"0001179110-15-000347","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-000347","line_url":"/filing/0001179110-15-000347#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":38.32,"price_display":"38.32","price_state":"stated","total_value":164776.0,"total_display":"164,776.00","shares_owned_after":53356.0,"shares_owned_after_display":"53,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-05","scope":"insider"},{"id":8772302,"accession":"0001179110-15-000347","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-000347","line_url":"/filing/0001179110-15-000347#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":39.36,"price_display":"39.36","price_state":"stated","total_value":27552.0,"total_display":"27,552.00","shares_owned_after":52656.0,"shares_owned_after_display":"52,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-05","scope":"insider"},{"id":6283833,"accession":"0001179110-14-017418","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001179110-14-017418","line_url":"/filing/0001179110-14-017418#line-9","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":34.97,"price_display":"34.97","price_state":"stated","total_value":90922.0,"total_display":"90,922.00","shares_owned_after":55056.0,"shares_owned_after_display":"55,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-02","scope":"insider"},{"id":6283829,"accession":"0001179110-14-017418","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-14-017418","line_url":"/filing/0001179110-14-017418#line-8","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":37.27,"price_display":"37.27","price_state":"stated","total_value":48451.0,"total_display":"48,451.00","shares_owned_after":52656.0,"shares_owned_after_display":"52,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-02","scope":"insider"},{"id":6283826,"accession":"0001179110-14-017418","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-14-017418","line_url":"/filing/0001179110-14-017418#line-7","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":34.89,"price_display":"34.89","price_state":"stated","total_value":41868.0,"total_display":"41,868.00","shares_owned_after":53956.0,"shares_owned_after_display":"53,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-02","scope":"insider"},{"id":6283819,"accession":"0001179110-14-017418","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-14-017418","line_url":"/filing/0001179110-14-017418#line-6","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":36.24,"price_display":"36.24","price_state":"stated","total_value":39864.0,"total_display":"39,864.00","shares_owned_after":53956.0,"shares_owned_after_display":"53,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-02","scope":"insider"},{"id":6283816,"accession":"0001179110-14-017418","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-14-017418","line_url":"/filing/0001179110-14-017418#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":37.41,"price_display":"37.41","price_state":"stated","total_value":26187.0,"total_display":"26,187.00","shares_owned_after":52656.0,"shares_owned_after_display":"52,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-02","scope":"insider"},{"id":6283813,"accession":"0001179110-14-017418","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-017418","line_url":"/filing/0001179110-14-017418#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":36.16,"price_display":"36.16","price_state":"stated","total_value":21696.0,"total_display":"21,696.00","shares_owned_after":53356.0,"shares_owned_after_display":"53,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-02","scope":"insider"},{"id":6406658,"accession":"0001179110-14-016615","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-14-016615","line_url":"/filing/0001179110-14-016615#line-7","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2964.0,"shares_display":"2,964","price_per_share":33.6,"price_display":"33.60","price_state":"stated","total_value":99590.4,"total_display":"99,590.40","shares_owned_after":52656.0,"shares_owned_after_display":"52,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-14","scope":"insider"},{"id":6406656,"accession":"0001179110-14-016615","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-14-016615","line_url":"/filing/0001179110-14-016615#line-6","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2935.0,"shares_display":"2,935","price_per_share":33.62,"price_display":"33.62","price_state":"stated","total_value":98674.7,"total_display":"98,674.70","shares_owned_after":52656.0,"shares_owned_after_display":"52,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-14","scope":"insider"},{"id":6406653,"accession":"0001179110-14-016615","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-14-016615","line_url":"/filing/0001179110-14-016615#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2065.0,"shares_display":"2,065","price_per_share":32.48,"price_display":"32.48","price_state":"stated","total_value":67071.2,"total_display":"67,071.20","shares_owned_after":55591.0,"shares_owned_after_display":"55,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-14","scope":"insider"},{"id":6406649,"accession":"0001179110-14-016615","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-016615","line_url":"/filing/0001179110-14-016615#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2036.0,"shares_display":"2,036","price_per_share":32.45,"price_display":"32.45","price_state":"stated","total_value":66068.2,"total_display":"66,068.20","shares_owned_after":55620.0,"shares_owned_after_display":"55,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-14","scope":"insider"},{"id":7006416,"accession":"0001179110-14-014742","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-14-014742","line_url":"/filing/0001179110-14-014742#line-7","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4200.0,"shares_display":"4,200","price_per_share":29.53,"price_display":"29.53","price_state":"stated","total_value":124026.0,"total_display":"124,026.00","shares_owned_after":53456.0,"shares_owned_after_display":"53,456","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-01","scope":"insider"},{"id":7006414,"accession":"0001179110-14-014742","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-14-014742","line_url":"/filing/0001179110-14-014742#line-6","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":29.53,"price_display":"29.53","price_state":"stated","total_value":121073.0,"total_display":"121,073.00","shares_owned_after":53556.0,"shares_owned_after_display":"53,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-01","scope":"insider"},{"id":7006412,"accession":"0001179110-14-014742","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-14-014742","line_url":"/filing/0001179110-14-014742#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":30.28,"price_display":"30.28","price_state":"stated","total_value":27252.0,"total_display":"27,252.00","shares_owned_after":52656.0,"shares_owned_after_display":"52,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-01","scope":"insider"},{"id":7006410,"accession":"0001179110-14-014742","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-014742","line_url":"/filing/0001179110-14-014742#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":30.27,"price_display":"30.27","price_state":"stated","total_value":24216.0,"total_display":"24,216.00","shares_owned_after":52656.0,"shares_owned_after_display":"52,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-01","scope":"insider"},{"id":6213595,"accession":"0001179110-14-013697","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-013697","line_url":"/filing/0001179110-14-013697#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":26.44,"price_display":"26.44","price_state":"stated","total_value":198300.0,"total_display":"198,300.00","shares_owned_after":52656.0,"shares_owned_after_display":"52,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6213591,"accession":"0001179110-14-013697","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-14-013697","line_url":"/filing/0001179110-14-013697#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":26.43,"price_display":"26.43","price_state":"stated","total_value":66075.0,"total_display":"66,075.00","shares_owned_after":52656.0,"shares_owned_after_display":"52,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6579759,"accession":"0001179110-14-012953","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-14-012953","line_url":"/filing/0001179110-14-012953#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7400.0,"shares_display":"7,400","price_per_share":29.77,"price_display":"29.77","price_state":"stated","total_value":220298.0,"total_display":"220,298.00","shares_owned_after":43756.0,"shares_owned_after_display":"43,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-14","filed_date":"2014-08-15","scope":"insider"},{"id":6579757,"accession":"0001179110-14-012953","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-012953","line_url":"/filing/0001179110-14-012953#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":29.78,"price_display":"29.78","price_state":"stated","total_value":74450.0,"total_display":"74,450.00","shares_owned_after":43656.0,"shares_owned_after_display":"43,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-14","filed_date":"2014-08-15","scope":"insider"},{"id":6579754,"accession":"0001179110-14-012953","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-14-012953","line_url":"/filing/0001179110-14-012953#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":30.37,"price_display":"30.37","price_state":"stated","total_value":3037.0,"total_display":"3,037.00","shares_owned_after":43656.0,"shares_owned_after_display":"43,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-14","filed_date":"2014-08-15","scope":"insider"},{"id":6904004,"accession":"0001179110-14-011384","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-011384","line_url":"/filing/0001179110-14-011384#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":34.09,"price_display":"34.09","price_state":"stated","total_value":255675.0,"total_display":"255,675.00","shares_owned_after":35656.0,"shares_owned_after_display":"35,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-02","scope":"insider"},{"id":6904000,"accession":"0001179110-14-011384","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-14-011384","line_url":"/filing/0001179110-14-011384#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":34.1,"price_display":"34.10","price_state":"stated","total_value":85250.0,"total_display":"85,250.00","shares_owned_after":35656.0,"shares_owned_after_display":"35,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-02","scope":"insider"},{"id":6748112,"accession":"0001179110-14-009751","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-14-009751","line_url":"/filing/0001179110-14-009751#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7300.0,"shares_display":"7,300","price_per_share":29.71,"price_display":"29.71","price_state":"stated","total_value":216883.0,"total_display":"216,883.00","shares_owned_after":27856.0,"shares_owned_after_display":"27,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-02","filed_date":"2014-06-04","scope":"insider"},{"id":6748110,"accession":"0001179110-14-009751","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-009751","line_url":"/filing/0001179110-14-009751#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":30.04,"price_display":"30.04","price_state":"stated","total_value":6008.0,"total_display":"6,008.00","shares_owned_after":27656.0,"shares_owned_after_display":"27,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-02","filed_date":"2014-06-04","scope":"insider"},{"id":6748107,"accession":"0001179110-14-009751","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-14-009751","line_url":"/filing/0001179110-14-009751#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":29.73,"price_display":"29.73","price_state":"stated","total_value":74325.0,"total_display":"74,325.00","shares_owned_after":27656.0,"shares_owned_after_display":"27,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-02","filed_date":"2014-06-04","scope":"insider"},{"id":6547862,"accession":"0001179110-14-008886","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-14-008886","line_url":"/filing/0001179110-14-008886#line-6","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7109.0,"shares_display":"7,109","price_per_share":31.48,"price_display":"31.48","price_state":"stated","total_value":223791.32,"total_display":"223,791.32","shares_owned_after":28047.0,"shares_owned_after_display":"28,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-19","filed_date":"2014-05-21","scope":"insider"},{"id":6547859,"accession":"0001179110-14-008886","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-14-008886","line_url":"/filing/0001179110-14-008886#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":31.49,"price_display":"31.49","price_state":"stated","total_value":75576.0,"total_display":"75,576.00","shares_owned_after":27756.0,"shares_owned_after_display":"27,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-19","filed_date":"2014-05-21","scope":"insider"},{"id":6547856,"accession":"0001179110-14-008886","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-008886","line_url":"/filing/0001179110-14-008886#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586752","owner_name":"Ertel Steven D","owner_url":"/insider/0001586752","role":"Officer (SVP & Chief Business Officer)","officer_title":"SVP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":391.0,"shares_display":"391","price_per_share":32.19,"price_display":"32.19","price_state":"stated","total_value":12586.29,"total_display":"12,586.29","shares_owned_after":27656.0,"shares_owned_after_display":"27,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-19","filed_date":"2014-05-21","scope":"insider"}],"next_cursor":"2014-05-19|6547856","ledger_fault":false,"count":{"value":53,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":53,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":53},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001280600","name":"ACCELERON PHARMA INC","url":"/issuer/0001280600","role":"Officer (EVP & Chief Operating Officer)","n_filings":22,"first_seen":"2014-04-24","last_seen":"2017-01-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001586752","retrieved_at":"2026-08-21T20:27:42+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}